PT Sarana Meditama Metropolitan Tbk Stock

Equities

SAME

ID1000126303

Healthcare Facilities & Services

End-of-day quote INDONESIA S.E. 06:00:00 2024-04-24 pm EDT 5-day change 1st Jan Change
254 IDR 0.00% Intraday chart for PT Sarana Meditama Metropolitan Tbk -1.55% -19.11%
Sales 2022 1,394B 86.4M Sales 2023 1,536B 95.21M Capitalization 5,381B 334M
Net income 2022 4.35B 270K Net income 2023 12.25B 760K EV / Sales 2022 4 x
Net Debt 2022 428B 26.56M Net Debt 2023 813B 50.43M EV / Sales 2023 4.03 x
P/E ratio 2022
1,182 x
P/E ratio 2023
439 x
Employees 2,613
Yield 2022 *
-
Yield 2023
-
Free-Float 21.75%
More Fundamentals * Assessed data
Dynamic Chart
PT Sarana Meditama Metropolitan Tbk Reports Earnings Results for the Full Year Ended December 31, 2023 CI
PT Sarana Meditama Metropolitan Tbk Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
PT Sarana Meditama Metropolitan Tbk(IDX:SAME) dropped from S&P Global BMI Index CI
PT Sarana Meditama Metropolitan Tbk Reports Earnings Results for the Half Year Ended June 30, 2023 CI
PT Sarana Meditama Metropolitan Tbk Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
PT Sarana Meditama Metropolitan Tbk Reports Earnings Results for the Full Year Ended December 31, 2022 CI
PT Sarana Meditama Metropolitan Tbk Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
PT Sarana Meditama Metropolitan Tbk Reports Earnings Results for the Half Year Ended June 30, 2022 CI
PT Sarana Meditama Metropolitan Tbk Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
PT Sarana Meditama Metropolitan Tbk Reports Earnings Results for the Full Year Ended December 31, 2021 CI
PT Sarana Meditama Metropolitan Tbk acquired a 13.84% stake in PT Kedoya Adyaraya Tbk for approximately IDR 220 million. CI
PT Sarana Meditama Metropolitan Tbk acquired an additional 2.52% stake in PT Kedoya Adyaraya Tbk for IDR 40.2 billion. CI
PT Sarana Meditama Metropolitan Tbk Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
PT Sarana Meditama Metropolitan Tbk(IDX:SAME) added to S&P Global BMI Index CI
Pt Sarana Meditama Metropolitan Tbk Reports Earnings Results for the Half Year Ended June 30, 2021 CI
More news
1 week-1.55%
Current month-5.22%
1 month-8.63%
3 months-14.19%
6 months-27.84%
Current year-19.11%
More quotes
1 week
246.00
Extreme 246
258.00
1 month
246.00
Extreme 246
284.00
Current year
246.00
Extreme 246
328.00
1 year
246.00
Extreme 246
406.00
3 years
242.00
Extreme 242
815.00
5 years
60.00
Extreme 60
815.00
10 years
60.00
Extreme 60
815.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 66 19-12-31
Director of Finance/CFO 73 20-12-31
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Chairman 66 19-12-31
Director/Board Member 64 19-12-31
Director/Board Member 82 21-05-09
More insiders
Date Price Change Volume
24-04-25 254 0.00% 580,600
24-04-24 254 0.00% 285,900
24-04-23 254 0.00% 583,600
24-04-22 254 0.00% 241,700
24-04-19 254 -1.55% 1,007,900

End-of-day quote INDONESIA S.E., April 24, 2024

More quotes
PT Sarana Meditama Metropolitan Tbk is an Indonesia-based company primarily engaged in providing healthcare service by building and operating hospitals. The Company hospitals are operated under the brand name of EMC Healthcare. The Company's specialty centers include cardiovascular center; digestive and bariatric center, and fertility and laparoscopy center. EMC Healthcare consists of seven hospitals that provide health services, namely EMC Alam Sutera Hospital, EMC Cibitung Hospital, EMC Cikarang Hospital, EMC Pekayon Hospital, EMC Pulomas Hospital, EMC Tangerang Hospital, and EMC Sentul Hospital. The Company also operates Grha Kedoya Hospital and Grha MM2100 Hospital through subsidiary PT Kedoya Adyaraya Tbk. The Company's subsidiaries include PT Sarana Meditama International, PT Sarana Meditama Anugerah, PT Sarana Meditama Nusantara, PT Kurnia Sejahtera Utama, PT Elang Medika Corpora, PT Sentosa Indah Sejahtera, and PT Kedoya Adyaraya Tbk.
More about the company